[go: up one dir, main page]

HK1051139A1 - Highly efficient delivery of a large therapeutic mass aerosol - Google Patents

Highly efficient delivery of a large therapeutic mass aerosol Download PDF

Info

Publication number
HK1051139A1
HK1051139A1 HK03103294A HK03103294A HK1051139A1 HK 1051139 A1 HK1051139 A1 HK 1051139A1 HK 03103294 A HK03103294 A HK 03103294A HK 03103294 A HK03103294 A HK 03103294A HK 1051139 A1 HK1051139 A1 HK 1051139A1
Authority
HK
Hong Kong
Prior art keywords
particles
agent
powder
dopa
delivery
Prior art date
Application number
HK03103294A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1051139B (en
Inventor
David A. Edwards
Richard P. Batycky
Lloyd Johnston
Original Assignee
Advanced Inhalation Research, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24365965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1051139(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Advanced Inhalation Research, Inc. filed Critical Advanced Inhalation Research, Inc.
Publication of HK1051139A1 publication Critical patent/HK1051139A1/en
Publication of HK1051139B publication Critical patent/HK1051139B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK03103294.4A 2000-06-09 2001-06-08 Highly efficient delivery of a large therapeutic mass aerosol HK1051139B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/591,307 US6858199B1 (en) 2000-06-09 2000-06-09 High efficient delivery of a large therapeutic mass aerosol
US20000591307P 2000-06-09
PCT/US2001/018491 WO2001095874A2 (en) 2000-06-09 2001-06-08 Highly efficient delivery of a large therapeutic mass aerosol

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK07105817.3A Division HK1098078A (en) 2000-06-09 2003-05-12 Highly efficient delivery of a large therapeutic mass aerosol

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK07105817.3A Addition HK1098078A (en) 2000-06-09 2003-05-12 Highly efficient delivery of a large therapeutic mass aerosol

Publications (2)

Publication Number Publication Date
HK1051139A1 true HK1051139A1 (en) 2003-07-25
HK1051139B HK1051139B (en) 2007-06-29

Family

ID=

Also Published As

Publication number Publication date
MXPA02012023A (es) 2004-08-19
NO20025873D0 (no) 2002-12-06
US20140178476A1 (en) 2014-06-26
JP2004503482A (ja) 2004-02-05
US20120093893A1 (en) 2012-04-19
CN1441670A (zh) 2003-09-10
WO2001095874A3 (en) 2003-01-16
CN100589796C (zh) 2010-02-17
US6858199B1 (en) 2005-02-22
DK1296663T3 (da) 2007-07-30
KR100697479B1 (ko) 2007-03-20
EP1296663B1 (en) 2007-03-21
US6921528B2 (en) 2005-07-26
US8628754B2 (en) 2014-01-14
US7556798B2 (en) 2009-07-07
DE60127407T2 (de) 2007-11-29
CA2412561C (en) 2009-05-12
US20090068274A1 (en) 2009-03-12
ES2283417T3 (es) 2007-11-01
DE60127407D1 (de) 2007-05-03
NZ523254A (en) 2004-07-30
PT1296663E (pt) 2007-06-22
IL153281A0 (en) 2003-07-06
US20020035993A1 (en) 2002-03-28
RU2275900C2 (ru) 2006-05-10
CA2412561A1 (en) 2001-12-20
PL360287A1 (en) 2004-09-06
JP2009019047A (ja) 2009-01-29
KR20030063117A (ko) 2003-07-28
WO2001095874A2 (en) 2001-12-20
ATE357222T1 (de) 2007-04-15
US20040076589A1 (en) 2004-04-22
AU7536801A (en) 2001-12-24
AU2001275368B2 (en) 2005-10-20
EP1767196A3 (en) 2009-02-25
EP1767196A2 (en) 2007-03-28
NO20025873L (no) 2003-02-06
EP1296663A2 (en) 2003-04-02
SI1296663T1 (sl) 2007-08-31

Similar Documents

Publication Publication Date Title
EP1296663B1 (en) Highly efficient delivery of a large therapeutic mass aerosol
AU2002230993B2 (en) Particles for inhalation having sustained release properties
EP1318785B1 (en) Pulmonary delivery of l-dopa
EP1487411B1 (en) Inhalable sustained therapeutic formulations
AU2006220411B2 (en) Inhalable Sustained Therapeutic Formulations
ES2389156T3 (es) Administración pulmonar de levodopa
US20080160098A1 (en) Use of simple amino acids to form porous particles
US7754242B2 (en) Inhalable sustained therapeutic formulations
US20220133708A1 (en) Inhalable sustained therapeutic formulations
HK1051139B (en) Highly efficient delivery of a large therapeutic mass aerosol
HK1098078A (en) Highly efficient delivery of a large therapeutic mass aerosol

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110608